Opendata, web and dolomites

TherGelFas SIGNED

Novel nanometrically structured therapeutic hydrogel as injectable for fascial tissues surrounding the nerves intended for preventive treatment of chronic pain

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TherGelFas project word cloud

Explore the words cloud of the TherGelFas project. It provides you a very rough idea of what is the project "TherGelFas" about.

corresponding    hydrogel    hydrogels    post    create    launch    biodegradable    scientific    unfortunately    surgery    hyaluronic    peripheral    treatment    made    times    pain    acid    scientifically    prevent    fascial    record    prevention    injections    talented    goals    acute    of    training    expects    scalable    documentation    antiinflamatory    materials    business    efficient    stages    originates    innovative    nanostructured    agencies    correctly    nerves    nerve    drugs    carrier    antiseptic    multimodal    protects    combining    thereby    biomaterials    medical    manufacturing    tissue    thergelfas    biocompatible    expertise    proof    blockade    manner    original    polymer    unsuccessful    medicinal    marketing    fast    regulatory    critical    injectable    load    chronic    host    replace    release    chronification    prepare    therapies    researcher    therapeutically    operative    chronifies    perform    achievement    porous    steroidal    first    improvement    strategies   

Project "TherGelFas" data sheet

The following table provides information about the project.

Coordinator
I+MED S.COOP. PEQUENA 

Organization address
address: CALLE ALBERT EINSTEIN 15
city: VITORIA-GASTEIZ
postcode: 1510
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 170˙121 €
 EC max contribution 170˙121 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2020-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    I+MED S.COOP. PEQUENA ES (VITORIA-GASTEIZ) coordinator 170˙121.00

Map

 Project objective

The key goals of the “TherGeLFas” project are: (a) the training of a talented experienced researcher in the fast growing field of innovative biomaterials for medical applications where the host and partner institutions have a critical knowledge and expertise; and, (b) the design and development of cost- efficient polymer materials in order to develop a new medicinal product for post-operative acute pain treatment and prevention of chronification. The aim of the research project and the main scientific challenge is thereby to develop a ‘therapeutically effective’ hydrogel based injectable product to be applied during and post-surgery in the fascial tissue that protects the nerves where the pain originates and chronifies. TherGelFas expects to create the proof of concept of a new medicinal product by combining advanced materials (a biodegradable, antiseptic and biocompatible carrier, made of porous nanostructured hydrogel based on hyaluronic acid) with the ability to load and release non-steroidal antiinflamatory drugs in a controlled manner. It is aimed for the improvement of the current multimodal strategies of peripheral nerve blockade injections used during and post-surgery in acute pain treatment to prevent it from becoming chronic and that unfortunately are unsuccessful many times. The first achievement will be that of the training of the experienced researcher in new areas of knowledge such as business development from original concept stages to production scale-up, manufacturing and marketing stages. The second achievement will be to scientifically assess whether these hydrogels can improve and replace currently used therapies, to develop a proof-of-concept scalable product. The third achievement will be to learn how to perform correctly the necessary steps needed to launch a product of this kind, such as record and prepare all the documentation needed to present the product to the corresponding regulatory agencies.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "THERGELFAS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "THERGELFAS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

EngPTC2 (2019)

Exploring new technologies for the next generation pulse tube cryocooler below 2K

Read More  

BB-SLM (2020)

Polychromatic digital optics for structured light

Read More  

NSTree (2020)

Understanding substrate delivery for cell wall biosynthesis in plants

Read More